ClinicalTrials.gg
Status unknownNCT03332706HMLandSAUpdated Nov 6, 2017

the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion

An observational study in Heavy Metal Toxicity and Spontaneous Abortion, sponsored by Peking Union Medical College Hospital. Status unknown at 1 site in China. Open to female participants. Per ClinicalTrials.gov, last updated 2017-11-06.

Sponsored by Peking Union Medical College Hospital · Observational

How we know

The sponsor has not verified this record recently (last verified Oct 2017), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Abortion, Spontaneous with a site in China — 4 open to participants now, 4 under way, none of them phase 3. Abortion, Spontaneous · China.

Planned enrollment
6th of 12
200 · median 200
Started
2017
with 1 other
Observational
12 of 15
2 open now
Registered
3rd of 15
by date
Lead sponsor
2 of 15
Peking Union Medical College Hospital

Among the 15 studies in Abortion, Spontaneous with a site in China, this one is the 6th largest by planned enrollment of the 12 observational ones that give a count, is one of 2 that started in 2017, is one of 12 observational ones, and was the 3rd registered.

Abortion, Spontaneous

221 studies on the registry are indexed under Abortion, Spontaneous; 44 are open to participants now.

Browse Abortion, Spontaneous studies →

Open to participants now

4 of the 15 studies in Abortion, Spontaneous with a site in China are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 36 Abortion, Spontaneous studies recruiting now, 11 (31%) set no upper age limit and 25 (69%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.

This study: female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Abortion, Spontaneous with a site in China, or all of them as a file.
02

Study summary

The aim of the study was to define the possible association between heavy iron level and the consequence of pregnancy especially spontaneous abortion and missed abortion. The study population will comprised the first-trimester pregnant women in the PUMCH (Peking Union Medicine College Hospital) during 2017 October to 2018 November. We categorised the patients into two groups, the study group where the patients suffered from spontaneous abortion or missed abortion, and the control group where the patients carry the normal live fetal for at least 8 weeks and ask for artificial abortion. All the cases included in the study were examined with respect to 6 kinds of heavy iron level in venous blood and urine, then correlation analysis was applied to define heavy iron level between two groups.

03

Conditions studied

  • Heavy Metal Toxicity
  • Spontaneous Abortion

Browse trials for

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

the first-trimester pregnant women in the PUMCH (Peking Union Medicine College Hospital) during 2017 October to 2018 November.

Inclusion criteria

  • early trimester pregnant women

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • SG

    Study Group is the group where the patients during observation suffer from spontaneous abortion or missed abortion,

    Other: observation

  • CG

    Control Group is where the patients carry the normal live fetal for at least 8 weeks

    Other: observation

Interventions

  • Otherobservation

    after the subjects are included into the groups,they are asked to do a questionaire.Then,we just observe the outcomes of pregnancy

06

What researchers measure

Primary outcomes

  1. blood's and urinary heavy metal level

    6 kinds of heavy metal:Pb,As,Hg,Gd,Cr,Se

    Time frame: 12months

07

Study locations

1 of 1 sites recruiting
  • Peking Union Medical College Hospital
    Pekin, Pekin 100730, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2017 (actual). Primary completion is estimated for Nov 2018, 12 months after the start.

Of 43 observational studies under Abortion, Spontaneous, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 91. This study's planned 12 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2017
First posted
Nov 6, 2017
StartActual
Oct 10, 2017
Primary completionEst.
Nov 1, 2018
CompletionEst.
Nov 30, 2018
Last update
Nov 6, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 6, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03332706
Responsible party
Sponsor
First posted
Nov 6, 2017
Start date
Oct 10, 2017
Primary completion
Nov 1, 2018 (estimated)
Completion
Nov 30, 2018 (estimated)
Last update
Nov 6, 2017

Study contacts

Liu xinyan
Contact
liuxymeng@163.com
18600008013
Liu xinyan
study director · Peking Union Medical College Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion